Gibbs Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.46M Buy
5,940
+282
+5% +$286K 0.72% 30
2025
Q4
$6.02M Sell
5,658
-619
-10% -$592K 1.46% 14
2025
Q3
$4.79M Sell
6,277
-823
-12% -$612K 1.08% 21
2025
Q2
$5.53M Buy
7,100
+393
+6% +$305K 1.07% 19
2025
Q1
$5.54M Buy
6,707
+2,317
+53% +$1.93M 1.34% 14
2024
Q4
$3.39M Buy
4,390
+3,631
+478% +$3.01M 0.92% 24
2024
Q3
$672K Buy
759
+115
+18% +$103K 0.22% 105
2024
Q2
$583K Buy
644
+277
+75% +$222K 0.24% 102
2024
Q1
$286K Buy
+367
New +$261K 0.16% 143

Other funds holding LLY

Gibbs Wealth Management's LLY Position: Q1 2026 in Review

Gibbs Wealth Management increased its Eli Lilly (LLY) stake by 5% in Q1 2026, buying an estimated $286K and bringing the position to 5,940 shares worth $5.46M. The position accounts for 0.72% of the portfolio, ranked #30.

Gibbs Wealth Management first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $6.02M in Q4 2025. 4,380 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Gibbs Wealth Management held 5,940 shares of Eli Lilly worth $5.46M as of Q1 2026.
  • Gibbs Wealth Management bought 282 Eli Lilly shares in Q1 2026, an estimated $286K.
  • Eli Lilly made up 0.72% of Gibbs Wealth Management's portfolio in Q1 2026, its #30 holding.
  • Gibbs Wealth Management first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
  • Gibbs Wealth Management's Eli Lilly position peaked at $6.02M in Q4 2025.
  • 4,380 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Gibbs Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.